Xbrane Biopharma

Major Shareholding Notification • Dec 4, 2023

Issuer Xbrane Biopharma AB

Holder

Serendipity Group AB

Instrument

Instrument	Aktier SE0007789409
Before the transaction
Shares	3,175,637
Voting rights	3,175,637
Transaction
Reason for major shareholding notification Sell
Date	30/11/2023
Limit for number of shares	10 %
Limit for number of votes	10 %
After the transaction
Quantity
Shares	2,569,861
Directly held voting rights	2,569,861
Indirectly held voting rights	0
Percentage
Directly held shares	8.6207 %
Directly held voting rights	8.6207 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

		Percentage of voting rights:	Number of underlying shares:
Shares		8.6207 %	2,569,861
	Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Cash settled	- Physically settled
Total		8.6207 %	2,569,861
Group Voting rights	total holdings 2,569,861 Percentage of voting rights 8.6207
Published	04/12/2023 14:40
Contact Name	Nils Fredrik Lagerstrand
Phone	0720902699	Email nilsfredrik@ehab.group
CLOSE	PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25